212 related articles for article (PubMed ID: 33203696)
41. Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.
Bergerot I; Arreaza GA; Cameron MJ; Burdick MD; Strieter RM; Chensue SW; Chakrabarti S; Delovitch TL
Diabetes; 1999 Sep; 48(9):1720-9. PubMed ID: 10480600
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in Mice.
Braster Q; Silvestre Roig C; Hartwig H; Beckers L; den Toom M; Döring Y; Daemen MJ; Lutgens E; Soehnlein O
PLoS One; 2016; 11(10):e0163922. PubMed ID: 27701440
[TBL] [Abstract][Full Text] [Related]
43. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
44. Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.
Lange S; Rocha-Ferreira E; Thei L; Mawjee P; Bennett K; Thompson PR; Subramanian V; Nicholas AP; Peebles D; Hristova M; Raivich G
J Neurochem; 2014 Aug; 130(4):555-62. PubMed ID: 24762056
[TBL] [Abstract][Full Text] [Related]
45. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
46. Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
Rondas D; Crèvecoeur I; D'Hertog W; Ferreira GB; Staes A; Garg AD; Eizirik DL; Agostinis P; Gevaert K; Overbergh L; Mathieu C
Diabetes; 2015 Feb; 64(2):573-86. PubMed ID: 25204978
[TBL] [Abstract][Full Text] [Related]
47. PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
Azzi J; Thueson L; Moore R; Abdoli R; Reijonen H; Abdi R
PLoS One; 2017; 12(1):e0169695. PubMed ID: 28081180
[TBL] [Abstract][Full Text] [Related]
48. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
49. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.
Lang J; Wang X; Liu K; He D; Niu P; Cao R; Jin L; Wu J
Appl Microbiol Biotechnol; 2017 Oct; 101(20):7653-7662. PubMed ID: 28889199
[TBL] [Abstract][Full Text] [Related]
50. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
51. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
Vitkov L; Hannig M; Minnich B; Herrmann M
Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
[TBL] [Abstract][Full Text] [Related]
52. The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis.
Chang HH; Dwivedi N; Nicholas AP; Ho IC
Arthritis Rheumatol; 2015 Sep; 67(9):2323-34. PubMed ID: 26019128
[TBL] [Abstract][Full Text] [Related]
53. New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes.
Jimeno R; Gomariz RP; Gutiérrez-Cañas I; Martínez C; Juarranz Y; Leceta J
Immunol Cell Biol; 2010 Oct; 88(7):734-45. PubMed ID: 20309012
[TBL] [Abstract][Full Text] [Related]
54. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa.
Byrd AS; Carmona-Rivera C; O'Neil LJ; Carlucci PM; Cisar C; Rosenberg AZ; Kerns ML; Caffrey JA; Milner SM; Sacks JM; Aliu O; Broderick KP; Reichner JS; Miller LS; Kang S; Robinson WH; Okoye GA; Kaplan MJ
Sci Transl Med; 2019 Sep; 11(508):. PubMed ID: 31484788
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of Cl-amidine against CLP-induced lethal septic shock in mice.
Zhao T; Pan B; Alam HB; Liu B; Bronson RT; Deng Q; Wu E; Li Y
Sci Rep; 2016 Nov; 6():36696. PubMed ID: 27819302
[TBL] [Abstract][Full Text] [Related]
56. Photochemical Control of Protein Arginine Deiminase (PAD) Activity.
Mondal S; Parelkar SS; Nagar M; Thompson PR
ACS Chem Biol; 2018 Apr; 13(4):1057-1065. PubMed ID: 29517899
[TBL] [Abstract][Full Text] [Related]
57. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
58. Targeting citrullination in autoimmunity: insights learned from preclinical mouse models.
Bruggeman Y; Sodré FMC; Buitinga M; Mathieu C; Overbergh L; Kracht MJL
Expert Opin Ther Targets; 2021 Apr; 25(4):269-281. PubMed ID: 33896351
[TBL] [Abstract][Full Text] [Related]
59. Insights into the study and origin of the citrullinome in rheumatoid arthritis.
Fert-Bober J; Darrah E; Andrade F
Immunol Rev; 2020 Mar; 294(1):133-147. PubMed ID: 31876028
[TBL] [Abstract][Full Text] [Related]
60. The Citrullination-Neutrophil Extracellular Trap Axis in Chronic Diseases.
Maronek M; Gardlik R
J Innate Immun; 2022; 14(5):393-417. PubMed ID: 35263752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
